Prenatal diagnosis of trisomi 13: A case report
Bu çalışmada 30 yaşında, iki yıllık infertilite öyküsü olan ve intrauterin inseminasyon sonucu gebe kalan, kromozomal anomaliler açısından prenatal tarama testinin trizomi 21 için yüksek risk gösterdiği ve amniyosentezle elde edilen hücrelerin 15 tanesinin sitogenetik incelemesinde 47,XY, + 13 karyotipi gösterilen bir olgu sunulmuştur. Gebelik 23. haftada misoprostol uygulamasıyla sona erdirilmiştir.
Trizomi 13'ün prenatal tanısı: Olgu sunumu
We report a 30 years-old primary infertile patient who conceived after intrauterine insemination. The prenatal screening test for chromosomal anomalies showed an increased risk for trisomy 21 at 15th gestational week. Amniotic fluid cytogenetic examination and karyotype of the cells obtained from the umbilical cord confirmed the diagnosis of trisomy 13.
___
- 1. Saller DN Jr, Canick JA, Biltzer MG, Palomaki GE, Schwartz S, Blakemore KJ, Haddow JE. Second trimester maternal serum analyte levels associated with fetal trisomy 13. Prenat Diagn 1999; 19:813-816.
- 2. Moore GE, Ruangvutilert P, Chatzimeletiou K, Bell G, Chen CK, Johnson P, Harper JC. Examination of trisomy 13, 18, and 21 foetal tissues at different gestational ages using FISH. Eur J Hum Genet 2000; 8:223-228.
- 3. Snijders RJM, Sebire NJ, Nioolaides KH. Maternal age and gestational age-specific risk for chromosomal defects. Fetal Diagn Ther 1995; 10:356-367.
- 4. Forrester MB, Merz RD. Trisomies 13 and 18: prenatal diagnosis and epidemiologic studies in Hawaii, 1986-1997. Genet Test 1999; 3:335-340.
- 5. Matthews AL. Chromosomal abnormalities: trisomy 18, trisomy 13, deletions and microdeletions . J Perinat Neonatal Nurs 1999; 13:59-75.
- 6. Feldman B, Ebrahim SA, Hazan SL, Gyi K, Johnson MP, Johnson A, Evans MI. Routine prenatal diagnosis of aneuploidy by FISH studies in high-risk pregnancies. Am J Med Genet 2000; 31: 233-238.
- 7. Jemmali M, Valat AS, Poulain P, Favre R, Bourgeot P, Subtil D, Puech F. Nuchal translucency: screening for chromosomal abnormalities and congenital malformations. Multicenter study. J Gynecol Obstet Biol Reprod (Paris) 1999; 28:538-543.
- 8. Spencer K, Ong C, Skentou H, Liao AW, Nicolaides KH. Screening for trisomy 13 by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagn 2000; 5:411-416.